• MLN8237 (Alisertib): Precision Workflows for Aurora A Inhibi

  2026-05-22

  MLN8237 (Alisertib) is redefining cancer biology research by enabling precise, reproducible inhibition of Aurora A kinase—a key driver of oncogenesis and tumor progression. This guide details experimental workflows, data-driven troubleshooting, and translational strategies that maximize the impact of MLN8237 in both cellular and in vivo tumor models.

• Dutasteride: Dual 5-Alpha-Reductase Inhibitor in Prostate Re

  2026-05-22

  Dutasteride’s precision as a dual 5-alpha-reductase inhibitor makes it indispensable for modeling androgen-driven cell biology in prostate cancer and BPH research. This article delivers advanced protocol optimization, troubleshooting, and translational insights for maximizing reproducibility and data quality using APExBIO’s Dutasteride.

• Apicidin as a Precision Tool: Beyond Toxicity to Epigenetic

  2026-05-21

  Explore Apicidin, a selective histone deacetylase inhibitor, as both a research tool and a lens into epigenetic engineering. This article uncovers its nuanced applications, mechanism, and practical insights that extend beyond reproductive toxicology.

• Novel Roles of ATG9A and PTOV1 in 14-3-3-Mediated Cancer Mec

  2026-05-21

  This study identifies ATG9A and PTOV1 as previously unrecognized 14-3-3 binding proteins, revealing new regulatory mechanisms in autophagy and oncogenesis. The findings offer a molecular framework for targeting cancer progression and provide new experimental avenues for dissecting protein-protein interactions in cell signaling.

• Phosbind Biotin LC: Practical Guide for Phosphoprotein Detec

  2026-05-20

  Phosbind Biotin LC enables sequence-independent detection of phosphorylated proteins on PVDF membranes in Western Blot workflows, offering a robust alternative to phospho-specific antibodies. It should not be used in aqueous-only protocols or for applications requiring long-term storage of working solutions.

• AT13387: Advanced Hsp90 Inhibition and Apoptosis Pathways

  2026-05-20

  Explore how AT13387, a potent Hsp90 inhibitor, uniquely modulates apoptosis and cell cycle arrest in cancer biology research. This article reveals mechanistic insights and practical protocols that go beyond existing guides, integrating breakthroughs in cell death regulation for advanced assay design.

• Technical Guide: Hoechst 33342/PI Double Staining Kit (K2237

  2026-05-19

  The Hoechst 33342/PI Double Staining Kit provides rapid, dual-fluorescence discrimination of viable, apoptotic, and necrotic cells by targeting chromatin condensation and membrane integrity. It is optimized for microscopy-based cell death assays in research settings. This kit is not intended for diagnostic or clinical applications.

• Biotin Azide: Bio-Orthogonal Biotinylation for Precision Lab

  2026-05-19

  Biotin Azide (N-(3-azidopropyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide) is a high-purity biotinylation reagent enabling bio-orthogonal labeling of alkynylated biomolecules through copper-catalyzed azide-alkyne cycloaddition. Its specificity, solubility profile, and compatibility with affinity purification using streptavidin make it a standard in molecular biology research. This article reviews the molecular rationale, mechanistic benchmarks, and protocol parameters for reliable use.

• Revisiting Sumatriptan Metabolism: CYP and MAO A Pathways Un

  2026-05-18

  This study reevaluates the metabolic fate of sumatriptan, a common migraine therapeutic, revealing that cytochrome P450 enzymes (CYP1A2, CYP2C19, CYP2D6) participate in its biotransformation alongside the previously established monoamine oxidase A (MAO A) pathway. These findings challenge conventional assumptions and offer new insights relevant to drug-drug interaction risk and the metabolic profiling of neuroactive compounds.

• Tumor-Targeted PAD4 Inhibition via m-PBA: Mechanistic Advanc

  2026-05-18

  This study introduces a meta-phenylboronic acid-modified PAD4 inhibitor (Compound 5i TFA) that selectively targets tumor cells and neutrophils by exploiting sialic acid-mediated uptake. The research demonstrates potent inhibition of histone H3 citrullination and neutrophil extracellular trap (NET) formation, resulting in marked antitumor efficacy with minimal off-target toxicity.

• Epoxomicin: Precision Proteasome Inhibitor in Cellular Pathw

  2026-05-17

  Epoxomicin sets the gold standard for selective, irreversible proteasome inhibition, empowering researchers to dissect ubiquitin-proteasome pathways with exceptional clarity. Discover how tailored workflows, troubleshooting strategies, and recent advances make this tool essential for inflammation, neurodegeneration, and protein degradation studies.

• TRPV1+ Nerve Stimulation Suppresses Systemic Inflammation vi

  2026-05-16

  Song et al. (2025) reveal that targeted stimulation of TRPV1+ peripheral somatosensory nerves at the nape initiates a somato-autonomic reflex, rapidly suppressing systemic inflammation by modulating both sympathetic and parasympathetic outflow. This mechanistic insight into neuro-immune regulation provides new avenues for the development of anti-inflammatory strategies and experimental models.

• Ceftolozane/Tazobactam: Advances Against Gram-Negative Resis

  2026-05-15

  Ceftolozane/tazobactam introduces a novel approach to treating complicated intraabdominal and urinary tract infections caused by multidrug-resistant Gram-negative bacteria. The study provides detailed evidence on its unique mechanism, pharmacodynamics, and clinical application, with implications for optimizing antibacterial strategies in resistance-prone settings.

• BAF53a Drives EMT and Poor Prognosis in Glioma: Evidence Rev

  2026-05-15

  Meng et al. (2017) demonstrate that BAF53a is upregulated in glioma, predicts poor patient survival, and mechanistically promotes glioma cell proliferation, invasion, and epithelial-mesenchymal transition (EMT). This review examines their methods, core findings, and the significance for glioma research and biomarker development.

• Cy5 NHS ester(Et): Practical Guidelines for Protein Labeling

  2026-05-14

  Cy5 NHS ester(Et) enables efficient, water-soluble fluorescent labeling of primary amines in proteins, peptides, and other biomolecules, supporting applications like immunofluorescence staining and flow cytometry. It should not be used in ethanol-based protocols or for long-term storage of labeling solutions. Researchers benefit from its high purity and controlled workflow compatibility for immediate-use protocols.

15122 records 1/1009 page Next 12345 下5页 Last page